All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know ALL.
The all Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the all Hub cannot guarantee the accuracy of translated content. The all and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The ALL Hub is an independent medical education platform, sponsored by Amgen, Autolus, Jazz Pharmaceuticals, and Pfizer and supported through an educational grant from the Hippocrate Conference Institute, an association of the Servier Group. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View ALL content recommended for you
How can NK cells act as reliable predictors and be translated to diagnostics and treatment in ALL?
Featured:
Srividya SwaminathanDuring the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, the ALL Hub spoke to Srividya Swaminathan, The Department of Systems Biology at the Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. We asked, How can natural killer (NK) cells act as reliable predictors and be translated to diagnostics and treatment in ALL?
How can NK cells act as reliable predictors and be translated to diagnostics and treatment in ALL?
Swaminathan reports the results of a study evaluating the phenotypic and functional deficiencies in NK cells of high-risk patients with ALL. Results from this study show that activated NK signature predicts poor clinical prognosis in high-risk patients with ALL.